Alzheimer's disease; new approach, new possibilities?July 28, 2005Antwerp, Belgium - Scientists from the Flanders Interuniversity Institute for Biotechnology (VIB) associated with the University of Antwerp have achieved a new breakthrough in their research on the origins of Alzheimer's disease. Their alternative approach opens up new prospects for developing a treatment which can slow the disease's progress. The researchers have shown that 'the plaques' which form in the brain of patients are linked to damage to nearby blood vessels. Leakage appears to occur between the blood vessels and the brain, as a result of which the plaques develop and the disease manifests itself. This research is published today in the 'American Journal of Pathology'. Alzheimer's disease Alzheimer's disease, a degenerative disease that gradually and progressively destroys brain cells, affects between 50% and 70% of all dementia patients and is therefore the major form of dementia. About 100,000 people suffer from this disease in Belgium. The damage caused to memory and mental functioning makes it one of today's most frightening syndromes. In particular, the first realization of the loss of any sense of reality is extremely difficult to accept. So, science continues to search feverishly for ways to treat the disease.
The formation of plaques plays a key role Alzheimer's disease is characterized by an increasing deposit of the amyloid-β protein in the brain. The accumulation of this protein results in 'plaques'; deposits which settle in the brain cells responsible for memory and observation. How the plaques develop is the key in the search for a treatment. Samir Kumar-Singh and his colleagues on a team headed by Christine Van Broeckhoven have unraveled how certain plaques are formed. In various mouse models, they demonstrate that the plaques attach primarily onto the blood vessels. The vessels show clear structural damage, so that the strictly-controlled separation between blood vessels and brain is compromised and leakage occurs. A new model as a first step towards a treatment? Under normal circumstances, the blood vessels transport the excess amyloid-β protein away from the brain. However, the protein has a harmful effect on blood vessel walls. This effect is perhaps strengthened as a result of ageing, which causes the protein to be removed less efficiently. The blood vessel loses strength and in its immediate vicinity the accumulation of the amyloid-β protein increases and plaques develop. Finally, the damage to the blood vessel is so great that it is no longer functional and other blood vessels take over its tasks. The results of the research of Samir Kumar-Singh opens up alternatives for developing new treatments. For example, a treatment which promotes the removal of the amyloid-β protein from the brain can significantly impede the onset of Alzheimer's disease. A new approach which might have far-reaching consequences. Additional research should make it possible to verify this in greater detail. VIB, Flanders Interuniversity Institute of Biotech | |||||||||||||||||||||
|
Related Alzheimers Disease Current Events and Alzheimers Disease News Articles Cold sore virus might play role in Alzheimer's disease A gene known to be a major risk factor for Alzheimer's disease puts out the welcome mat for the virus that causes cold sores, allowing the virus to be more active in the brain compared to other forms of the gene. Study offers window into human behavior, brain disease UCSF scientists have identified a cell population that is a primary target of the degenerative brain disease known as frontotemporal dementia, which is as common as Alzheimer's disease in patients who develop dementia before age 65. New imaging compound might 'see' Alzheimer's earlier A new imaging molecule that can detect and map plaques and tangles in the brains of people with Alzheimer's disease could eventually lead to earlier diagnosis of the devastating disease, researchers at the University of California, Los Angeles report in the Dec. 21, 2006, issue of the New England Journal of Medicine. Testosterone therapy may prevent Alzheimer's disease Researchers at the University of Southern California have discovered a direct link between loss of testosterone and the development of an Alzheimer's-like disease in mice. They also discovered that testosterone treatment slows progression of the disease. Androgen therapy may slow progress of Alzheimer's disease Experiments on mouse models of Alzheimer's disease (AD) suggest that treatment with male sex hormones might slow its progression. Protein 'fingerprint' in spinal fluid could spot Alzheimer's disease Scientists collaborating at Cornell University in Ithaca and Weill Cornell Medical College in New York City have identified a panel of 23 protein biomarkers in cerebrospinal fluid that acts as a neurochemical "fingerprint," which doctors might use someday to identify patients living with Alzheimer's disease. Study shows cats can succumb to feline Alzheimer's disease Ageing cats can develop a feline form of Alzheimer's disease, a new study reveals. Scientists at the Universities of Edinburgh, St Andrews, Bristol and California have identified a key protein which can build up in the nerve cells of a cat's brain and cause mental deterioration. Scientists develop a new way to target Alzheimer's disease The pathological embrace between two proteins plays a key role in the development of Alzheimer's disease by triggering the formation of neuron-killing plaques of amyloid beta protein. Now a group of scientists at NYU School of Medicine have devised a way to reduce amyloid beta deposition by interfering with the deadly embrace of these proteins. Complaints About Memory Are Associated With Alzheimer-Related Brain Damage Researchers at Rush University Medical Center found that having complaints about memory problems is associated with changes in the brain related to Alzheimer's disease. They reported their findings in the November 2006 issue of Neurology. More insight into Alzheimer's disease with Stanford discovery of possible cause A peacekeeper in the body's defenses against infection may hold the key to understanding-and eventually treating-Alzheimer's disease. Researchers at the Stanford University School of Medicine discovered that when a molecule responsible for dialing down the immune system malfunctions in the brain cells of mice, the rodents develop symptoms of the degenerative brain disease. More Alzheimers Disease Current Events and Alzheimers Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||